Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
Abstract Hemophilia A (HA) is caused by mutations in coagulation factor VIII (FVIII). Genome editing in conjunction with patient-derived induced pluripotent stem cells (iPSCs) is a promising cell therapy strategy, as it replaces dysfunctional proteins resulting from genetic mutations with normal pro...
| 發表在: | Experimental and Molecular Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Nature Publishing Group
2025-01-01
|
| 在線閱讀: | https://doi.org/10.1038/s12276-024-01375-z |
